Clinical trials seek to advance and improve treatment options for a variety of conditions, including Alzheimer’s disease.
They are designed to answer questions about the safety and effectiveness of potential new medications.
Clinical research trials must be performed before a new medication or treatment can be approved for use and made available to the general public.
There are common traits that people must have to participate in a trial, called eligibility criteria. Common criteria include age, gender, medical history, and other medical conditions.
Right now, there are more than 400,000 research trials in progress around the world.1
Many conditions affect diverse groups of people, so it is important to have diverse groups of people participating in research. Different people may respond differently to treatments.